Publications

130. Changes in physical activity before and after the diagnosis of dyslipidemia and the risk of atrial fibrillation: a population-based study in South Korea. Prev Med Rep. 2025;57:103200. Published 2025 Aug 8. doi:10.1016/j.pmedr.2025.103200 

129. Mental health risks associated with a family history of chronic diseases: A nationwide population-based cross-sectional study. J Psychosom Res. 2025;196:112340. doi:10.1016/j.jpsychores.2025.112340

128. Older Age Threshold for Oxaliplatin Benefit in Stage II to III Colorectal Cancer. JAMA Netw Open. 2025;8(8):e2525660. Published 2025 Aug 1. doi:10.1001/jamanetworkopen.2025.25660 

127. Combined impact of prediabetes and fatty liver index on cardiometabolic outcomes and mortality in middle aged adults: a nationwide cohort study. Cardiovasc Diabetol. 2025;24(1):279. Published 2025 Jul 10. doi:10.1186/s12933-025-02793-7 

126. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406(10500):235-260. doi:10.1016/S0140-6736(25)01037-2 

125. Increasing incidence of ADHD among children, adolescents and young adults: COVID-19 pandemic-driven trend in Korea (2012-2023). BMJ Ment Health. 2025;28(1):e301662. Published 2025 Jun 20. doi:10.1136/bmjment-2025-301662

124. Young Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease Have an Increased Risk of Early-Onset Cancer: A Nationwide Cohort Study Differentiating the Risk of 23 Site-Specific Cancers. Clin Gastroenterol Hepatol. Published online May 8, 2025. doi:10.1016/j.cgh.2025.01.042 

123. Identification of potentially effective drugs for metabolic dysfunction-associated steatotic liver disease against liver cirrhosis: In-silico drug repositioning-based retrospective cohort study. PLoS One. 2025;20(6):e0323880. Published 2025 Jun 4. doi:10.1371/journal.pone.0323880 

122. Association between green space and hepatocellular carcinoma risk: a retrospective cohort study of seven South Korean metropolitan areas. Int J Environ Health Res. Published online May 29, 2025. doi:10.1080/09603123.2025.2508890 

121. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease With Sudden Sensorineural Hearing Loss Among Older Adults. Laryngoscope Investig Otolaryngol. 2025;10(3):e70156. Published 2025 May 10. doi:10.1002/lio2.70156 

120. Combined effects of statin medication adherence and fine particulate air pollution on cardiovascular disease among older adults. J Gerontol A Biol Sci Med Sci. Published online May 9, 2025. doi:10.1093/gerona/glaf079 

119. Association between cholecystectomy and chronic kidney disease risk: a nationally retrospective cohort study. Transl Gastroenterol Hepatol. 2025;10:27. Published 2025 Apr 10. doi:10.21037/tgh-24-98 

118. Development of a Predictive Model for Metabolic Syndrome Using Noninvasive Data and its Cardiovascular Disease Risk Assessments: Multicohort Validation Study. J Med Internet Res. 2025;27:e67525. Published 2025 May 2. doi:10.2196/67525

117. Association between short-term exposure to air pollution and cardiovascular disease in older adults: A time-stratified case-crossover study in South Korea. Atmospheric Environment. 2025 June 1;350:121130. doi: 10.1016/j.atmosenv.2025.121130

116. Combined association of particulate matter and changes in physical activity on metabolic syndrome and profiles. Discov Public Health. 2025 April 26;22:191. doi: 10.1186/s12982-025-00578-7

115. Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study : MASLD, MetALD, and dementia risk. BMC Gastroenterol. 2025 Apr 29;25(1):308. doi: 10.1186/s12876-025-03814-1

114.  Significant Hepatic Fat Loss after Metabolic Dysfunction-associated Steatotic Liver Disease: Beware of Misclassification as Absence of Disease.  J Hepatol. 2025 Apr 22:S0168-8278(25)00250-8. doi: 10.1016/j.jhep.2025.04.023

113. Biomedical applications of organoids in genetic diseases. Med Rev (2021). 2024 Dec 24;5(2):152-163. doi: 10.1515/mr-2024-0077. eCollection 2025 Apr.

112. Correspondence to letter to the editor 1 on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study". Clin Mol Hepatol. 2025 Apr;31(2):e208-e209. doi: 10.3350/cmh.2024.1171. Epub 2025 Jan 6.

111. Correspondence to letter to the editor 2 on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study". Clin Mol Hepatol. 2025 Apr;31(2):e210-e211. doi: 10.3350/cmh.2024.1175. Epub 2025 Jan 6.

110. Association between antibiotic use and the risk of rheumatoid arthritis: a retrospective cohort study in South Korea. Rheumatology (Oxford). 2025 Apr 1;64(4):1732-1740. doi: 10.1093/rheumatology/keae483.

109. Cardiovascular benefit of statin use against air pollutant exposure in older adults. Eur J Prev Cardiol. 2025 Mar 18;32(4):288-298. doi: 10.1093/eurjpc/zwae061.

108. Risk of hematologic malignancies in psoriasis and rheumatoid arthritis patients using long term TNF-α inhibitors: a retrospective nationwide study. Sci Rep. 2025 Mar 7;15(1):7949. doi: 10.1038/s41598-025-90996-z.

107. Association between Antibiotic Use and Subsequent Risk of Breast Cancer: A Nationwide Retrospective Cohort Study in South Korea. Cancer Prev Res (Phila). 2025 Mar 3;18(3):125-133. doi: 10.1158/1940-6207.CAPR-24-0154.

106. Association of cholecystectomy with short-term and long-term risks of depression and suicide. Sci Rep. 2025 Feb 24;15(1):6557. doi: 10.1038/s41598-025-87523-5.

105. Association of Balance Impairment with Risk of Incident Dementia among Older Adults. J Prev Alzheimers Dis. 2024;11(1):130-137. doi: 10.14283/jpad.2023.79

104. Antibiotic Exposure and Risk of Parkinson Disease in South Korea: A Nationally Representative Retrospective Cohort Study. Neurol Clin Pract. 2025 Feb;15(1):e200400. doi: 10.1212/CPJ.0000000000200400. Epub 2024 Nov 15.

103. Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation. Clin Mol Hepatol. 2025 Feb;31(Suppl):S285-S300. doi: 10.3350/cmh.2024.0323. Epub 2024 Aug 19.

102. Author Correction: Tramadol use and incident dementia in older adults with musculoskeletal pain: a population-based retrospective cohort study. Sci Rep. 2025 Jan 22;15(1):2845. doi: 10.1038/s41598-025-86870-7.

101. Combined Effects of Air Pollution and Changes in Physical Activity With Cardiovascular Disease in Patients With Dyslipidemia. J Am Heart Assoc. 2024 Dec 3;13(23):e035933. doi: 10.1161/JAHA.124.035933. Epub 2024 Nov 27.

100. Tramadol use and incident dementia in older adults with musculoskeletal pain: a population-based retrospective cohort study. Sci Rep. 2024 Oct 11;14(1):23850. doi: 10.1038/s41598-024-74817-3.

99. Association between antibiotic use and cardiovascular diseases in metabolic dysfunction-associated steatotic liver disease: A nationally representative retrospective cohort study. Hepatol Res. 2024 Sep 30. doi: 10.1111/hepr.14115. Online ahead of print.

98. Incidence of hearing loss following COVID-19 among young adults in South Korea: a nationwide cohort study. EClinicalMedicine. 2024 Jul 29;75:102759. doi: 10.1016/j.eclinm.2024.102759. eCollection 2024 Sep.

97. Antibiotic exposure and depression incidence: A cohort study of the Korean population. Psychiatry Res. 2024 Sep;339:115992. doi: 10.1016/j.psychres.2024.115992. Epub 2024 May 29.

96. Association between antibiotics use and osteoporotic fracture risk: a nationally representative retrospective cohort study. Arch Osteoporos. 2024 Aug 30;19(1):81. doi: 10.1007/s11657-024-01438-8.

95. Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study. Liver Cancer. 2023 Dec 22;13(4):426-437. doi: 10.1159/000535943. eCollection 2024 Aug.

94. Validity of fatty liver prediction scores for diagnosis of fatty liver by Fibroscan. Hepatobiliary Pancreat Dis Int. 2024 Aug;23(4):353-360. doi: 10.1016/j.hbpd.2023.02.009. Epub 2023 Feb 24.

93. Risk of pulmonary embolism and deep vein thrombosis following COVID-19: a nationwide cohort study. MedComm (2020). 2024 Jul 14;5(7):e655. doi: 10.1002/mco2.655. eCollection 2024 Jul.

92. Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study. Clin Mol Hepatol. 2024 Jul;30(3):487-499. doi: 10.3350/cmh.2024.0145. Epub 2024 May 7.

91. Association between body composition and subsequent cardiovascular diseases among 5-year breast cancer survivors. Nutr Metab Cardiovasc Dis. 2024 Jul;34(7):1787-1797. doi: 10.1016/j.numecd.2024.03.018. Epub 2024 Mar 15.

90. Inverse association with COVID-19 vaccination status of the incidence of pneumonia after SARS-CoV-2 infection: A nationwide retrospective cohort study. J Infect Public Health. 2024 Apr;17(4):650-656. doi: 10.1016/j.jiph.2024.02.005. Epub 2024 Feb 10.

89. Association between antibiotic use and subsequent risk of prostate cancer: A retrospective cohort study in South Korea. Int J Urol. 2024 Apr;31(4):325-331. doi: 10.1111/iju.15364. Epub 2023 Dec 21.

88. Associations of cholecystectomy with metabolic health changes and incident cardiovascular disease: a retrospective cohort study. Sci Rep. 2024 Feb 8;14(1):3195. doi: 10.1038/s41598-024-53161-6.

87. Nutrients associated with metabolic dysfunction-associated steatotic liver disease. J Hepatol. 2024 Feb;80(2):e81-e82. doi: 10.1016/j.jhep.2023.09.013. Epub 2023 Sep 16.

86. Protective effect of vaccination on the risk of cardiovascular disease after SARS-CoV-2 infection. Clin Res Cardiol. 2024 Feb;113(2):235-245. doi: 10.1007/s00392-023-02271-8. Epub 2023 Jul 31.

85. Moderate-to-Vigorous Physical Activity Changes with the Risk of SARS-CoV-2 Infection: A Nested Case-Control Study. Stud Health Technol Inform. 2024 Jan 25;310:1505-1506. doi: 10.3233/SHTI231266.

84. Predicted Body Composition Against COVID-19: A Potential Digital Health Strategy. Stud Health Technol Inform. 2024 Jan 25;310:1503-1504. doi: 10.3233/SHTI231265.

83. COVID-19-related cardiovascular disease risk due to weight gain: a nationwide cohort study. Eur J Med Res. 2024 Jan 2;29(1):2. doi: 10.1186/s40001-023-01569-7.

82. Association Between Antibiotic Exposure and Thyroid Cancer: A Nationwide Cohort Study in South Korea. Thyroid. 2024 Jan;34(1):112-122. doi: 10.1089/thy.2023.0235. Epub 2023 Dec 18.

81. Association of allergic disease with Parkinson's disease: A nationally representative retrospective cohort study. Allergol Int. 2024 Jan;73(1):107-114. doi: 10.1016/j.alit.2023.07.005. Epub 2023 Aug 5.

80. Association of Thyroid Hormone Medication Adherence With Risk of Dementia. J Clin Endocrinol Metab. 2023 Dec 21;109(1):e225-e233. doi: 10.1210/clinem/dgad447.

79. Increased Estimated GFR Is Negatively Associated With the Risk of SARS-CoV-2 Infection and Severe COVID-19 Within Normal to Mildly Decreased Levels: Nested Case-Control Study. J Korean Med Sci. 2023 Dec 18;38(49):e415. doi: 10.3346/jkms.2023.38.e415.

78. Association of weight changes with SARS-CoV-2 infection and severe COVID-19 outcomes: A nationwide retrospective cohort study. J Infect Public Health. 2023 Dec;16(12):1918-1924. doi: 10.1016/j.jiph.2023.10.002. Epub 2023 Oct 5.

77. Risk of Bell's palsy following SARS-CoV-2 infection: a nationwide cohort study. Clin Microbiol Infect. 2023 Dec;29(12):1581-1586. doi: 10.1016/j.cmi.2023.08.014. Epub 2023 Aug 21.

76. Reversal of nonalcoholic fatty liver disease reduces the risk of cardiovascular disease among Korean. Medicine (Baltimore). 2023 Nov 3;102(44):e35804. doi: 10.1097/MD.0000000000035804.

75. Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study. EClinicalMedicine. 2023 Oct 28;65:102292. doi: 10.1016/j.eclinm.2023.102292. eCollection 2023 Nov.

74. Novel discovery of PDPN-positive CAFs contributing to tumor-associated lymphangiogenesis through mesenchymal to lymphatic endothelial transition in intrahepatic cholangiocarcinoma. Genes Dis. 2023 Mar 28;10(6):2226-2228. doi: 10.1016/j.gendis.2023.02.023. eCollection 2023 Nov.

73. Association Between Hearing Impairment and Incident Depression: A Nationwide Follow-up Study. Laryngoscope. 2023 Nov;133(11):3144-3151. doi: 10.1002/lary.30654. Epub 2023 Mar 10.

72. Association of balance impairment with risk of incident cardiovascular diseases among older adults. Eur J Med Res. 2023 Oct 24;28(1):455. doi: 10.1186/s40001-023-01426-7.

71. Association between antibiotics and asthma risk among adults aged over 40 years: a nationally representative retrospective cohort study. BMJ Open Respir Res. 2023 Oct;10(1):e001643. doi: 10.1136/bmjresp-2023-001643.

70. Long-term antibiotic use and risk of hepatocellular carcinoma later in life: a nationwide cohort study of 9.8 million participants. Cancer Commun (Lond). 2023 Oct;43(10):1174-1177. doi: 10.1002/cac2.12484. Epub 2023 Sep 13.

69. Poorer outcomes following COVID-19 infection for patients with depression: A cohort analysis in South Korea. Ann Acad Med Singap. 2023 Aug 30;52(8):411-419. doi: 10.47102/annals-acadmedsg.202331.

68. Inverse association between changes in systolic and diastolic blood pressure and risk of depression: A nationally representative cohort study. J Affect Disord. 2023 Aug 15;335:49-56. doi: 10.1016/j.jad.2023.04.107. Epub 2023 May 1.

67. Association of antibiotic use with risk of lung cancer: A nationwide cohort study. J Infect Public Health. 2023 Jul;16(7):1123-1130. doi: 10.1016/j.jiph.2023.05.006. Epub 2023 May 9.

66. Letter regarding "Non-alcoholic fatty liver disease: Definition and subtypes". Clin Mol Hepatol. 2023 Jul;29(3):810-811. doi: 10.3350/cmh.2023.0129. Epub 2023 May 8.

65. Association of post-smoking cessation changes in fasting serum glucose with changes in predicted fatty liver score. Sci Rep. 2023 Jun 26;13(1):10300. doi: 10.1038/s41598-023-37194-x.

64. Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia. Rev Cardiovasc Med. 2023 Jun 14;24(6):173. doi: 10.31083/j.rcm2406173. eCollection 2023 Jun.

63. Exercise Frequency Reduction Is Associated With Higher Risk of Infection in Newly Diagnosed Diabetes: A Nationally Representative Cohort Study. J Korean Med Sci. 2023 Jun 12;38(23):e176. doi: 10.3346/jkms.2023.38.e176.

62. Association of Physical Activity With SARS-CoV-2 Infection and Severe Clinical Outcomes Among Patients in South Korea. JAMA Netw Open. 2023 Apr 3;6(4):e239840. doi: 10.1001/jamanetworkopen.2023.9840.

61. Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants. Cardiovasc Diabetol. 2023 Mar 28;22(1):71. doi: 10.1186/s12933-023-01805-8.

60. Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma. Front Endocrinol (Lausanne). 2023 Mar 20;14:1150360. doi: 10.3389/fendo.2023.1150360. eCollection 2023.

59. Distinct effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on major depressive disorder: A nationwide cohort study. Asian J Psychiatr. 2023 Mar;81:103436. doi: 10.1016/j.ajp.2022.103436. Epub 2022 Dec 29.

58. Sex-separated NAFLD/NASH Scores May Improve Predictive Performance. Clin Gastroenterol Hepatol. 2023 Mar;21(3):855-856. doi: 10.1016/j.cgh.2022.04.041. Epub 2022 May 25.

57. Association between the dual use of electronic and conventional cigarettes and NAFLD status in Korean men. Tob Induc Dis. 2023 Feb 24;21:31. doi: 10.18332/tid/159167. eCollection 2023.

56. Association of Change in Smoking Status and Subsequent Weight Change with Risk of Nonalcoholic Fatty Liver Disease. Gut Liver. 2023 Jan 15;17(1):150-158. doi: 10.5009/gnl220038. Epub 2022 Nov 3.

55. Association between visit-to-visit fasting glycemic variability and depression: a retrospective cohort study in a representative Korean population without diabetes. Sci Rep. 2022 Nov 4;12(1):18692. doi: 10.1038/s41598-022-22302-0.

54. Development and validation of a nonalcoholic fatty liver disease-based self-diagnosis tool for diabetes. Ann Transl Med. 2022 Nov;10(21):1158. doi: 10.21037/atm-22-2195.

53. Association between community-level social trust and the risk of dementia: A retrospective cohort study in the Republic of Korea. Front Public Health. 2022 Oct 6;10:913319. doi: 10.3389/fpubh.2022.913319. eCollection 2022.

52. Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies. Clin Mol Hepatol. 2022 Oct;28(4):933-934. doi: 10.3350/cmh.2022.0267. Epub 2022 Sep 14.

51. Association between antibiotics and dementia risk: A retrospective cohort study. Front Pharmacol. 2022 Sep 26;13:888333. doi: 10.3389/fphar.2022.888333. eCollection 2022.

50. Clinical analysis of deceased donor liver transplantation in the treatment of hepatocellular carcinoma with segmental portal vein tumor thrombus: A long-term real-world study. Front Oncol. 2022 Sep 20;12:971532. doi: 10.3389/fonc.2022.971532. eCollection 2022.

49. Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study. Arthritis Res Ther. 2022 Jul 28;24(1):180. doi: 10.1186/s13075-022-02871-1.

48. Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease. Gut Liver. 2022 Jul 15;16(4):589-598. doi: 10.5009/gnl210256. Epub 2021 Nov 3.

47. Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults. Clin Mol Hepatol. 2022 Jul;28(3):510-521. doi: 10.3350/cmh.2021.0332. Epub 2022 Mar 17.

46. Association of the presence of allergic disease with subsequent risk of liver cancer in a nationwide retrospective cohort among Koreans. Sci Rep. 2022 Jun 14;12(1):9856. doi: 10.1038/s41598-022-14147-4.

45. Health-Screening-Based Chronic Obstructive Pulmonary Disease and Its Effect on Cardiovascular Disease Risk. J Clin Med. 2022 Jun 2;11(11):3181. doi: 10.3390/jcm11113181.

44. Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study. J Clin Med. 2022 May 19;11(10):2865. doi: 10.3390/jcm11102865.

43. Association of physical activity with stroke among long-term colorectal cancer survivors. J Cancer Surviv. 2022 Apr;16(2):366-373. doi: 10.1007/s11764-021-01031-9. Epub 2021 Jun 17.

42. Estimating Risk of Cardiovascular Disease Among Long-Term Colorectal Cancer Survivors: A Nationwide Cohort Study. Front Cardiovasc Med. 2022 Jan 17;8:721107. doi: 10.3389/fcvm.2021.721107. eCollection 2021.

41. Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years. JAMA Netw Open. 2021 Nov 1;4(11):e2136008. doi: 10.1001/jamanetworkopen.2021.36008.

40. Differential Effectiveness of Tenofovir and Entecavir for Prophylaxis of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Depending on Coexisting Cirrhosis and Prior Exposure to Antiviral Therapy: A Systematic Review and Meta-analysis. J Clin Gastroenterol. 2021 Oct 1;55(9):e77-e86. doi: 10.1097/MCG.0000000000001548.

39. M(6)A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma. Cancer Res. 2021 Sep 15;81(18):4778-4793. doi: 10.1158/0008-5472.CAN-21-0468. Epub 2021 Jul 23.

38. A combined Cox and logistic model provides accurate predictive performance in estimation of time-dependent probabilities for recurrence of intrahepatic cholangiocarcinoma after resection. Hepatobiliary Surg Nutr. 2021 Aug;10(4):464-475. doi: 10.21037/hbsn.2020.01.07.

37. Association of first, second, and third-line bDMARDs and tsDMARD with drug survival among seropositive rheumatoid arthritis patients: Cohort study in A real world setting. Semin Arthritis Rheum. 2021 Aug;51(4):685-691. doi: 10.1016/j.semarthrit.2021.06.002. Epub 2021 Jun 7.

36. Association of Short-Term Particulate Matter Exposure among 5-Year Cancer Survivors with Incident Cardiovascular Disease: A Time-Stratified Case-Crossover Study. Int J Environ Res Public Health. 2021 Jul 28;18(15):7996. doi: 10.3390/ijerph18157996.

35. Associations between alcohol consumption and cardiovascular disease among long-term survivors of colorectal cancer: a population-based, retrospective cohort study. BMC Cancer. 2021 Jun 16;21(1):710. doi: 10.1186/s12885-021-08436-w.

34. Association of weight fluctuation with cardiovascular disease risk among initially obese adults. Sci Rep. 2021 May 12;11(1):10152. doi: 10.1038/s41598-021-89666-7.

33. Probabilistic ratiocination of hepatocellular carcinoma after resection: evaluation of expected to be promising approaches. Ann Transl Med. 2021 May;9(9):778. doi: 10.21037/atm-20-4828.

32. Association of Air Pollutants with Incident Chronic Kidney Disease in a Nationally Representative Cohort of Korean Adults. Int J Environ Res Public Health. 2021 Apr 4;18(7):3775. doi: 10.3390/ijerph18073775.

31. Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance. Ann Transl Med. 2020 Nov;8(21):1414. doi: 10.21037/atm-20-2951.

30. Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma in the Setting of Cirrhosis. Liver Transpl. 2020 Sep;26(9):1202-1203. doi: 10.1002/lt.25758. Epub 2020 May 12.

29. Trajectory and Functional Analysis of PD-1(high) CD4(+)CD8(+) T Cells in Hepatocellular Carcinoma by Single-Cell Cytometry and Transcriptome Sequencing. Adv Sci (Weinh). 2020 May 18;7(13):2000224. doi: 10.1002/advs.202000224. eCollection 2020 Jul.

28. Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma. Theranostics. 2020 Apr 6;10(12):5384-5397. doi: 10.7150/thno.41616. eCollection 2020.

27. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram. Hepatobiliary Pancreat Dis Int. 2020 Apr;19(2):138-146. doi: 10.1016/j.hbpd.2020.02.005. Epub 2020 Feb 21.

26. Latent Risk Intrahepatic Cholangiocarcinoma Susceptible to Adjuvant Treatment After Resection: A Clinical Deep Learning Approach. Front Oncol. 2020 Feb 19;10:143. doi: 10.3389/fonc.2020.00143. eCollection 2020.

25. Impact of EBV infection and immune function assay for lymphoproliferative disorder in pediatric patients after liver transplantation: A single-center experience. Hepatobiliary Pancreat Dis Int. 2020 Feb;19(1):3-11. doi: 10.1016/j.hbpd.2019.12.005. Epub 2019 Dec 27.

24. Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities. Ann Transl Med. 2019 Dec;7(23):744. doi: 10.21037/atm.2019.12.37.

23. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort. Liver Transpl. 2019 Nov;25(11):1723-1724. doi: 10.1002/lt.25624. Epub 2019 Sep 16.

22. Reply to: IL-26 and the prognosis of hepatocellular carcinoma after resection. Hepatobiliary Pancreat Dis Int. 2019 Oct;18(5):502. doi: 10.1016/j.hbpd.2019.07.011. Epub 2019 Jul 25.

21. Expression of IL-26 predicts prognosis of patients with hepatocellular carcinoma after surgical resection. Hepatobiliary Pancreat Dis Int. 2019 Jun;18(3):242-248. doi: 10.1016/j.hbpd.2019.03.006. Epub 2019 Mar 27.

20. Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma. BMC Cancer. 2019 Mar 8;19(1):208. doi: 10.1186/s12885-019-5420-z.

19. The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches. Front Pharmacol. 2019 Jan 8;9:1428. doi: 10.3389/fphar.2018.01428. eCollection 2018.

18. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma. Cancer Med. 2018 Sep;7(9):4665-4677. doi: 10.1002/cam4.1704. Epub 2018 Jul 31.

17. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma. Lancet Gastroenterol Hepatol. 2018 Aug;3(8):529. doi: 10.1016/S2468-1253(18)30158-4.

16. Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis. Int J Biol Sci. 2018 Jul 27;14(10):1333-1342. doi: 10.7150/ijbs.26045. eCollection 2018.

15. Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis. Hepatol Int. 2018 Jul;12(4):330-338. doi: 10.1007/s12072-018-9881-y. Epub 2018 Jun 26.

14. Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection: Novel concerns. J Hepatol. 2018 Jun;68(6):1315-1316. doi: 10.1016/j.jhep.2018.01.039. Epub 2018 Feb 20.

13. Nervous system and primary liver cancer. Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):286-292. doi: 10.1016/j.bbcan.2018.04.002. Epub 2018 Apr 13.

12. Risk stratification of hepatic encephalopathy in liver cirrhosis patients: Novel strategy with novel concerns. Hepatology. 2018 Apr;67(4):1635-1636. doi: 10.1002/hep.29747. Epub 2018 Mar 1.

11. Current status of liver transplantation for cholangiocarcinoma. Liver Transpl. 2018 Mar;24(3):440. doi: 10.1002/lt.24974. Epub 2018 Feb 9.

10. Nomogram predicting pulmonary metastasis of hepatocellular carcinoma after liver transplantation. Oncotarget. 2017 Dec 19;9(2):2425-2434. doi: 10.18632/oncotarget.23418. eCollection 2018 Jan 5.

9. Rictor Deficiency Aggravates Hepatic Ischemia/Reperfusion Injury in Mice by Suppressing Autophagy and Regulating MAPK Signaling. Cell Physiol Biochem. 2018;45(6):2199-2212. doi: 10.1159/000488165. Epub 2018 Mar 10.

8. miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA). Oncotarget. 2017 Jul 6;8(59):100819-100830. doi: 10.18632/oncotarget.19044. eCollection 2017 Nov 21.

7. Risk factors and survival outcomes of biliary complications after adult-to-adult living donor liver transplantation. United European Gastroenterol J. 2017 Nov;5(7):997-1006. doi: 10.1177/2050640616688994. Epub 2017 Jan 18.

6. Intrahepatic cholangiocarcinoma arising from HBV infection may be a highly selected population for liver transplantation. Hepatology. 2017 Nov;66(5):1703-1704. doi: 10.1002/hep.29413. Epub 2017 Sep 29.

5. Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection. Int J Biol Sci. 2017 Sep 21;13(10):1234-1241. doi: 10.7150/ijbs.21149. eCollection 2017.

4. Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection. BMC Cancer. 2017 Jul 3;17(1):464. doi: 10.1186/s12885-017-3464-5.

3. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncotarget. 2017 Mar 7;8(10):17292-17300. doi: 10.18632/oncotarget.14079.

2. Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection. Can J Gastroenterol Hepatol. 2017;2017:6543423. doi: 10.1155/2017/6543423. Epub 2017 Nov 12.

1. Role of Osteopontin in Liver Diseases. Int J Biol Sci. 2016 Aug 6;12(9):1121-8. doi: 10.7150/ijbs.16445. eCollection 2016.